Wednesday, June 10, 2026

pharma · Pulmonary Arterial Hypertension (PAH)

AOP Orphan Pharmaceuticals

News and analysis for AOP Orphan Pharmaceuticals on NovaPharmaNews — regulatory, clinical, and market coverage.

Wien, AT HQ
EMA registrant Type
Company details
Status
Public
HQ
Wien, AT
Programs
2
Drugs
1
Patents
7
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning AOP Orphan Pharmaceuticals — regulatory, clinical, and market coverage.

News and analysis for AOP Orphan Pharmaceuticals on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning AOP Orphan Pharmaceuticals yet.

Back to company overview →